Clinical TrialsSearch results
Number of results: 892
Recruiting
- Multicenter NHPH Eradication Study
- Non-Helocobactor Pylori Helicobactor infection gastiritis
- Suzuki HIdekazu
- 2024-05-08
Recruiting
- Phase II study to evaluate the Synbiotics efficacy on reducing the incidence of postoperative infectious complications after liver resection.
- Patients with primary biliary tract cancer without distant metastases(with/without tissue diagnosis)
- Matsuyama Ryusei
- 2024-04-25
Recruiting
- A Phase 3, Open-label Study Assessing Self-administered Rocatinlimab (AMG 451) in Subjects With Moderate-to-severe AD
- Atopic Dermatitis
- Chen Sarah
- 2024-04-23
Not yet recruiting
- The acute effects of different types of exercise on glycemic rpofiles in people with diabetes; A single-center prospective study
- Diabetes mellitus
- Hayashi Akinori
- 2024-04-19
Recruiting
- A study to investigate the efficacy and safety of efgartigimod PH20 SC in adult participants with active idiopathic inflammatory myopathy
- Idiopathic inflammatory myopathy
- Sabine Coppieters
- 2024-04-18
Recruiting
- A study on the immune response and safety of vaccine against respiratory syncytial virus given to adults 18 to 49 years of age at increased risk for respiratory syncytial virus disease (RSV), compared to older adults 60 years of age and above
- Respiratory Syncytial Virus Disease
- Okawa Yasutoshi
- 2024-04-08
Recruiting
- H. pylori rescue eradication therapy with rifabutin, sitafloxacin, and vonoprazan
- Helicobacter pylori infection
- Sue Soichiro
- 2024-03-27
Recruiting
- Research on the safety of hyperthermic chemotherapy administered at the time of resection of disseminated lesions for pleural dissemination of malignant tumors occurring in children and AYA generations
- pleural dissemination of malignant tumor
- Kitagawa Norihiko
- 2024-03-27
Not yet recruiting
- Association between exercise skeletal muscle oxygen consumption and sarcopenia complications in patients with chronic heart failure
- Heart failure
- Taiki Yamasaki
- 2024-03-27
Recruiting
- A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor low/HER2-negative Breast Cancer
- Breast Cancer
- Inoguchi Akihiro
- 2024-03-20